Published in Biochem Biophys Res Commun on March 26, 2013
QSpike tools: a generic framework for parallel batch preprocessing of extracellular neuronal signals recorded by substrate microelectrode arrays. Front Neuroinform (2014) 0.91
Human Cerebrospinal Fluid Promotes Neuronal Viability and Activity of Hippocampal Neuronal Circuits In Vitro. Front Cell Neurosci (2016) 0.75
Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke (2004) 3.07
Symptomatic acute occlusion of the internal carotid artery: reappraisal of urgent vascular reconstruction based on current stroke imaging. J Vasc Surg (2008) 2.11
Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke (2004) 1.58
The future of Alzheimer's disease: the next 10 years. Prog Neurobiol (2011) 1.31
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimers Res Ther (2010) 1.30
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem (2007) 1.28
Cerebrospinal fluid of brain trauma patients inhibits in vitro neuronal network function via NMDA receptors. Ann Neurol (2009) 1.24
Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis. J Neurosci Res (2005) 1.16
The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans. Neuroimage (2004) 1.14
Development of brain infarct volume as assessed by magnetic resonance imaging (MRI): follow-up of diffusion-weighted MRI lesions. J Magn Reson Imaging (2004) 1.12
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging (2007) 1.10
Early and differential diagnosis of dementia and mild cognitive impairment: design and cohort baseline characteristics of the German Dementia Competence Network. Dement Geriatr Cogn Disord (2009) 1.08
Skill-based objectives for specialist training in old age psychiatry. Int J Geriatr Psychiatry (2003) 1.07
Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav Sci Law (2004) 1.07
Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage (2007) 1.04
Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke (2007) 1.03
Development and pharmacological modulation of embryonic stem cell-derived neuronal network activity. Exp Neurol (2007) 1.02
Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populations. BMC Neurosci (2009) 0.98
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics. J Neurol (2012) 0.97
Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. J Clin Psychopharmacol (2005) 0.97
Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res (2010) 0.95
Cryopreserved rat cortical cells develop functional neuronal networks on microelectrode arrays. J Neurosci Methods (2003) 0.94
MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology (2002) 0.93
The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res (2010) 0.93
Association between traffic-related air pollution, subclinical inflammation and impaired glucose metabolism: results from the SALIA study. PLoS One (2013) 0.89
Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum Mol Genet (2012) 0.89
Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations. Stroke (2003) 0.89
Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. J Neural Transm (Vienna) (2008) 0.89
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial. Neuropsychiatr Dis Treat (2011) 0.88
Evaluation of multiple-session delay eyeblink conditioning comparing patients with focal cerebellar lesions and cerebellar degeneration. Behav Brain Res (2010) 0.88
Single particle detection of Abeta aggregates associated with Alzheimer's disease. Biochem Biophys Res Commun (2007) 0.88
Air pollution and subclinical airway inflammation in the SALIA cohort study. Immun Ageing (2014) 0.88
Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation (2003) 0.88
Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimers Dis (2005) 0.87
P2Y receptor-mediated excitation in the posterior hypothalamus. Eur J Neurosci (2006) 0.87
Platelet GPIIb/IIIa receptor antagonists in human ischemic brain disease. Curr Vasc Pharmacol (2008) 0.87
Significance of the perfusion-diffusion mismatch in chronic cerebral ischemia. J Magn Reson Imaging (2006) 0.85
Diffusion-weighted imaging in acute stroke--a tool of uncertain value? Cerebrovasc Dis (2002) 0.85
Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Int J Geriatr Psychiatry (2008) 0.85
Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients. Alzheimers Dement (2009) 0.85
Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study. Eur Arch Psychiatry Clin Neurosci (2011) 0.84
Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form. J Alzheimers Dis (2009) 0.84
Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol (2002) 0.84
Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms. Schizophr Res (2005) 0.84
Initial ischemic event: perfusion-weighted MR imaging and apparent diffusion coefficient for stroke evolution. Radiology (2005) 0.84
Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients. Alzheimers Dement (2009) 0.84
Lesion patterns in successful and failed thrombolysis in middle cerebral artery stroke. Neuroradiology (2009) 0.84
Storage of a naturally acquired conditioned response is impaired in patients with cerebellar degeneration. Brain (2013) 0.83
Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients. J Clin Psychopharmacol (2013) 0.83
Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man. Behav Brain Res (2003) 0.83
Microalbuminuria indicates long-term vascular risk in patients after acute stroke undergoing in-patient rehabilitation. BMC Neurol (2012) 0.83
Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementia. Int Psychogeriatr (2012) 0.83
Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J Neural Transm (Vienna) (2009) 0.82
Transient reduction of spontaneous neuronal network activity by sublethal amyloid beta (1-42) peptide concentrations. J Neural Transm (Vienna) (2009) 0.82
The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats. Clinics (Sao Paulo) (2010) 0.82
Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication. Neuropsychiatr Dis Treat (2005) 0.82
Odor identification in Alzheimer's disease and depression. Aging Clin Exp Res (2007) 0.81
Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion. Cerebrovasc Dis (2011) 0.81
Virtual arterial endoscopy as a diagnostic aid in a patient with basilar artery fenestration and thromboembolic pontine infarct. AJNR Am J Neuroradiol (2002) 0.81
Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke (2004) 0.80
Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice. Alzheimers Res Ther (2011) 0.80
EEG and the Test for the Early Detection of Dementia with Discrimination from Depression (TE4D): a validation study. Int J Geriatr Psychiatry (2004) 0.80
Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity. J Neurol Sci (2004) 0.80
Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid. J Alzheimers Dis (2011) 0.80
Vascular risk prediction in ischemic stroke patients undergoing in-patient rehabilitation - insights from the investigation of patients with ischemic stroke in neurologic rehabilitation (INSIGHT) registry. Int J Stroke (2012) 0.79
Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective. Int Psychogeriatr (2012) 0.79
Circadian rhythm of neutrophil counts and granulocyte macrophage-colony stimulating factor (GM-CSF) under clozapine treatment: a case report. World J Biol Psychiatry (2010) 0.79
A survey of geriatric psychiatry training across Europe. Int Psychogeriatr (2012) 0.79
Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial. World J Biol Psychiatry (2011) 0.79
APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease. J Alzheimers Dis (2013) 0.78
Time is brain?--Surgical revascularization of acute symptomatic occlusion of the internal carotid artery up to one week. Ann Vasc Surg (2013) 0.78
Anosognosia and depression in patients with Alzheimer's dementia. Arch Gerontol Geriatr (2013) 0.78
Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge. Clin Neurophysiol (2005) 0.78
Variable platelet response to aspirin in patients with ischemic stroke. Cerebrovasc Dis (2007) 0.78
Structural correlates of motor adaptation deficits in patients with acute focal lesions of the cerebellum. Exp Brain Res (2014) 0.78
[Integrating patients with dementia and anosognosia into community care by a psychogeriatric consultation service]. Psychiatr Prax (2011) 0.77
Antipsychotic drugs influence transport of the beta-adrenergic antagonist [3H]-dihydroalprenolol into neuronal and blood cells. World J Biol Psychiatry (2004) 0.77
Neuronal network properties of human teratocarcinoma cell line-derived neurons. Brain Res (2004) 0.77
Disturbance of cultured rat neuronal network activity depends on concentration and ratio of leucine and alpha-ketoisocaproate: implication for acute encephalopathy of maple syrup urine disease. Pediatr Res (2003) 0.77
Estrogen receptor beta gene (ESRbeta) 3'-UTR variants in Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 0.77
Reduced benefit from mnemonic strategies in early-stage Alzheimer's disease: a brief testing-the-limits paradigm for clinical practice. J Neurol (2010) 0.76
Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia. Hum Psychopharmacol (2002) 0.76
An ultrasensitive assay for diagnosis of Alzheimer's disease. Rejuvenation Res (2008) 0.76
Facial affect recognition performance and event-related potentials in violent and non-violent schizophrenia patients. Neuropsychobiology (2013) 0.76
Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms. J Neural Transm (Vienna) (2011) 0.76
Aldolase C/zebrin II is released to the extracellular space after stroke and inhibits the network activity of cortical neurons. Neurochem Res (2006) 0.76
Cerebellar infarction after gamma knife radiosurgery of a vestibular schwannoma. Neurology (2007) 0.76
Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity. Behav Brain Funct (2005) 0.75
Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban. Neurol Int (2012) 0.75
Resumption of food and fluid intake in Alzheimer's disease with severe apathy following intravenous citalopram. Psychiatry Clin Neurosci (2012) 0.75
Inhibition of p38-mitogen-activated protein kinase may protect from clozapine-induced agranulocytosis. World J Biol Psychiatry (2004) 0.75
Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord (2016) 0.75